Serial changes of plasma nitrate in the acute phase of Kawasaki disease

Pediatrics International

Volumn 45, Issue 4, 2003, Pages 421-425

  Ikemoto, Yumiko ^a   Teraguchi, Masayuki ^a   Ono, Atushi ^b   Kino, Minoru ^c   Yoshimura, Ken ^a   Kobayashi, Yohnosuke ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Izuo Hospital   (Japan)

^c Nakano General Hospital   (Japan)

Author keywords

Coronary artery lesion; Kawasaki disease; Nitric oxide

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; NITRATE; NITRIC OXIDE;

ACUTE DISEASE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; INFLAMMATION; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS;

EID: 0141630832     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2003.01756.x     Document Type: Article

References (20)

1. Takahashi M. Kawasaki syndrome. In: Allen, HD, Clark, EB, (eds). Moss and Adams' Heart Disease in Infants, Children, and Adolescents, 6th edn. Lippincott, Williams & Wilkins, Philadelphia, USA, 2001; 1216-25.
2. Wong HR, Carcillo JA, Burckart G, Kaplan SS. Nitric oxide production in critically ill patients. Arch. Dis. Child 1996; 74: 482-9.
3. Meulemans A, Delsenne F. Measurement of nitrite and nitrate levels in biological samples by capillary electrophoresis. J. Chromato. 1994; 660: 401-4.
4. Tsukahara H, Kikuchi K, Matsuda M et al. Endogenous nitric oxide production in Kawasaki disease. Scand. J. Clin. Laboratory Invest. 1997; 57: 43-7.
5. Iizuka T, Oishi K, Sasaki M et al. Nitric oxide and aneurysm formation in Kawasaki disease. Acta Paediatr. 1997; 86: 470-3.
6. Mori K, Hayabuchi Y, Kuroda Y et al. Retrograde holodiastolic flow in the abdominal aorta detected by pulse Doppler echocardiography in patients with Kawasaki disease. Eur. J. Pediatr. 2000; 159: 509-14.
7. Japan Kawasaki Disease Research Committee. Diagnostic guideline of Kawasaki disease. 4th Revision. Tokyo, Japan 1984.
8. de Zorzi A, Colan SD, Gauvereau K et al. Coronary dimensions may be misclassified as normal in Kawasaki disease. J. Pediatr. 1998; 133: 254-8.
9. Harada K. Intravenous γ-globulin treatment in Kawasaki disease. Acta Paediatr. Jpn. 1991; 33: 805-10.
10. Morshage H, Kok B, Huizenga JR et al. Nitrite and nitrate determination in plasma: a critical evaluation. Clin. Chem. 1995; 41: 892-6.
11. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine - what does this measure tell us about the activity of the endogenous nitric oxide system? Curr. Opin. Nephrol. Hypertension 1998; 7: 59-62.
12. Stoclet JC, Muller B, Andriantsitohaina R, Keschyov A. Overproduction of nitric oxide in pathophysiology of blood vessels. Biochemistry 1998; 63: 976-83.
13. Takahashi H, Nakanishi T, Nishimura M et al. Measurements of serum levels of nitrate ions in men and women: implications of endothelium-derived relaxing factor in blood pressure regulation and atherosclerosis. J. Cardiovasc. Pharm. 1992; 20: S214-6.
14. Lin CY, Lin CC, Hwang B, Chiang B. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J. Pediatr. 1992; 121: 924-6.
15. Maury CPJ, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor-α in patients with Kawasaki disease. J. Laboratory Clin. Med. 1989; 113: 651-4.
16. Fujiwara T, Fujiwara H, Nakano H. Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Circulation 1988; 78: 345-50.
17. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 1978; 61: 100-7.
18. Aeberhard EE, Henderson SA, Arabolos NS et al. Non-steroidal anti-inflammatory drugs inhibit expression of the inducible nitric oxide synthase gene. Biochim. Biophys. Res. Comm. 1995; 208: 1053-9.
19. Shimokawa H. Primary endothelial dysfunction: Atherosclerosis. J. Mol. Cell Cardiol. 1999; 31: 23-37.
20. Toutouzas PC, Tousoulis D, Davies J. Nitric oxide synthesis in atherosclerosis. Eur. Heart J. 1998; 19: 1504-11.